InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Whitfield Roy A, Director. Insider active across 2 companies, notably NEKTAR THERAPEUTICS. Cumulatively, 6 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €16k. History available since 16 September 2021. The latest transaction was filed on 14 June 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Whitfield Roy A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
30,000 shares@ US$0.571.7% of flowCommon StockSEC:0001209191-23-037538:0
10,200 shares0Common StockSEC:0001209191-22-050816:0
10,200 shares0Common StockSEC:0001209191-21-057708:0
40,000 shares@ US$13.8096.7% of flowCommon StockSEC:0001209191-21-056728:0
3,750 sharesCommon StockSEC:0001127602-16-041475:0
3,750 sharesCommon StockSEC:0001127602-16-041475:1
6 of 6 declarations
About Whitfield Roy A
Roy A. Whitfield is a Board Member of Nektar Therapeutics. He participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset to the board.
